Brussels, 29/01/2013 (Agence Europe) - On 28 January, the European Medicines Agency (EMA) announced that it had been asked by France to review third- and fourth-generation combined oral contraceptives, “to determine whether there is a need to restrict the use of these medicines to women who cannot take other combined oral contraceptives”. The EMA stated that this is the first time a member state has approached it to call on it to issue Europe-wide recommendations on this kind of medicine...